Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

Pages

18 results
4:27 PM, Aug 22, 2014  |  BC Extra | Top Story

EMA to review Cubist's ceftolozane/tazobactam

FDA granted Priority Review to Cubist's NDA for the IV combination therapy, which comprises the cephalosporin antibiotic
4:49 PM, Dec 16, 2013  |  BC Extra | Top Story

Cubist product meets in Phase III cIAI trials

of market exclusivity if it is approved. Cubist has worldwide rights to ceftolozane (CXA-101), a cephalosporin antibiotic
5:16 PM, Jun 01, 2012  |  BC Extra | Top Story

Forest, Nabriva in antibiotic deal

to treat patients after they leave the hospital and would complement its Teflaro ceftaroline, a cephalosporin antibiotic
6:09 PM, Feb 22, 2010  |  BC Extra | Top Story

FDA approves Cayston

in cystic fibrosis (CF) patients with Pseudomonas aeruginosa infections. Gilead plans to launch the inhaled cephalosporin antibiotic
5:47 PM, Feb 19, 2010  |  BC Extra | Top Story

CHMP rebuffs ceftobiprole, J&J ends deal

against J&J related to the pharma's handling of clinical studies for the broad spectrum anti-MRSA cephalosporin antibiotic
4:17 PM, Dec 30, 2009  |  BC Extra | Top Story

Basilea off on FDA complete response

partners' 2005 deal by causing a delay in the approval of the broad spectrum anti-MRSA cephalosporin antibiotic
7:22 PM, Dec 14, 2009  |  BC Extra | Top Story

Cubist to acquire Calixa

in cash and up to $310 million in milestones. Cubist will gain CXA-101 , a cephalosporin antibiotic
6:02 PM, Dec 10, 2009  |  BC Extra | Top Story

FDA panel backs Gilead's Cayston

150 mg of Cayston given twice daily. The PDUFA date is Feb. 13. The inhaled cephalosporin antibiotic
7:06 PM, Feb 24, 2009  |  BC Extra | Top Story

Basilea off on Zevtera MAA delay

against J&J related to the pharma's handling of clinical studies for the broad spectrum anti-MRSA cephalosporin antibiotic
2:59 PM, Nov 26, 2008  |  BC Extra | Top Story

Basilea falls on ceftobiprole delay

J&J submitted a complete response to a March approvable letter for the broad spectrum anti-MRSA cephalosporin antibiotic

Pages